Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Getahun, Belete ^a   Ameni, Gobena ^a,b   Biadgilign, Sibhatu ^c   Medhin, Girmay ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c JIMMA UNIVERSITY   (Ethiopia)

Author keywords

DOTS; Ethiopia; Mortality cohort; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY WEIGHT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DEATH; ETHIOPIA; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH CENTER; HUMAN; INFANT; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SHORT COURSE THERAPY; STANDARDIZATION; STATISTICAL ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; TUBERCULOSIS; UNDERWEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETHIOPIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; YOUNG ADULT;

EID: 79955892691     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-127     Document Type: Article

References (43)

1. World Health Organization Global Tuberculosis Control: a short update to the 2009 report. 2009, World Health Organization, Accessed at March 20, 2011, World Health Organization., http://www.who.int/tb/publications/global_report/2009/update/en/index.html
2. World Health Organization Global Tuberculosis Control Surveillance, Planning, Financing. 2005, World Health Organization, Accessed at March 20, 2011, World Health Organization., http://www.who.int/tb/publications/global_report/2005/en/
3. Federal Ministry of Health of Ethiopia (FMOH) Guidelines for program and clinical management of drug resistant tuberculosis. Addis Ababa 2009, FMOH, First, Federal Ministry of Health of Ethiopia (FMOH).
4. World Health Organization Country Profile: Ethiopia, Global Tuberculosis Control Surveillance, Planning, Financing, Who Report. 2008, 105-108. WHO/HTM/TB/2008.393, World Health Organization.
5. Ministry of Health of Ethiopia (MOH) Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual. 2008, Addis Ababa: MOH, 4, Ministry of Health of Ethiopia (MOH).
6. Toungoussova OS, Nizovtseva NI, Mariandyshev AO, Caugant DA, Sandven P, Bjune G. Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999. Eur J Clin Microbiol Infect Dis 2004, 23:174-179. 10.1007/s10096-003-1080-6, 14735405.
7. Shilova MV. Specific features of the spread of tuberculosis in Russia at the end of the 20th century. Ann N Y Acad Sci 2001, 953:124-132.
8. Atun RA, Samyshkin YA, Drobniewski F, et al. Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ 2005, 83:217-223. 2624209, 15798846.
9. Vasankari T, Holmstrom P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC Public Health 2007, 7:291. 10.1186/1471-2458-7-291, 2099439, 17935630.
10. Zevallos M, Justman JE. Tuberculosis in the elderly. ClinGeriatr Med 2003, 19:121-138.
11. Summary and Statistical Report of the 2007 Population and Housing Census Results. 51. , http://www.csa.gov.et/pdf/Cen2007_prelimineray.pdf
12. Federal Ministry of Health (FMOH), Planning and Programming Department Health and Health Related Indicators. 2000, EC. Addis Ababa, Ethiopia, Federal Ministry of Health (FMOH), Planning and Programming Department.
13. WHO Tuberculosis Programme Framework for effective tuberculosis control. WHO document. WHO/TB/94 1994, 179. Geneva, Switzerland: World Health Organization, WHO Tuberculosis Programme.
14. Bao QS, Du YH, Lu CY. Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort study. BMC Public Health 2007, 7:344. 10.1186/1471-2458-7-344, 2220000, 18047661.
15. Xianyi C, Fengzeng Z, Hongjin D, Liya W, Lixia W, Xin D, Chin DP. The DOTS strategy in China: results and lessons after 10 years. Bull World Health Organ 2002, 80(6):430-6. 2567538, 12131998.
16. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998, 2(5):372-7.
17. Vasantha M, Gopi PG, Subramani R. Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India. Indian J Tuberc 2008, 55(2):64-9.
18. Kolappan C, Subramani R, Karunakaran K, Narayanan PR. Mortality of tuberculosis patients in Chennai, India. Bull World Health Organ 2006, 84:555-560. 10.2471/BLT.05.022087, 2627396, 16878229.
19. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J, Narayanan PR. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002, 6(9):780-8.
20. Borgdorff MW, Veen J, Kalisvaart NA, Nagelkerke N. Mortality among tuberculosis patients in The Netherlands in the period 1993-1995. Eur Respir J 1998, 11(4):816-20. 10.1183/09031936.98.11040816, 9623682.
21. Lawn SD, Acheampong JW. Pulmonary tuberculosis in adults: factors associated with mortality at a Ghanaian teaching hospital. West Afr J Med 1999, 18:270-274.
22. Tan KL, Sin Fam Lam KN, Chew LS. Mortality of patients while on treatment for active tuberculosis. Singapore Med J 1996, 37:258-260.
23. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001, 5:1000-1005.
24. Vree M, Huong NT, Duong BD, Sy DN, Van le N, Co NV, Cobelens FG, Borgdorff MW. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study. BMC Public Health 2007, 7:134. 10.1186/1471-2458-7-134, 1925078, 17605770.
25. Humphries MJ, Byfield SP, Darbyshire JH, et al. Deaths occurring in newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest 1984, 78:149-158.
26. Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis 2003, 7:742-750.
27. Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW, Sterling TR. A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates. Int J Tuberc Lung Dis 2002, 6:1114-1117.
28. Kolappan C, Subramani R, Kumaraswami V, Santha T, Narayanan PR. Excess mortality and risk factors for mortality among a cohort of TB patients from rural South India. Int J Tuberc Lung Dis 2008, 12:81-86.
29. Datiko DG, Lindtjorn B. Mortality in successfully treated tuberculosis patients in southern Ethiopia: retrospective follow-up study. Int J Tuberc Lung Dis 2010, 14(7):1-6.
30. Khan A, Timothy R, Reves R, Andrew V, Robert HC, . the Tuberculosis Trails Consortium Lack of weight gains and relapse risk in a large Tuberculosis treatment trial. Am. J Respir. Crit. Care Med 2006, 174:344-48. 10.1164/rccm.200511-1834OC, 16709935, the Tuberculosis Trails Consortium.
31. Kim HJ, Kwon SY, Yoon HI, Lee CT, Kim YW, Chung HS, Han SK, Shim YS, Lee JH. Nutritional deficit as a negative prognostic factor in patients with miliary tuberculosis. Eur Respir J 2008, 32(4):1031-6. 10.1183/09031936.00174907, 18508814.
32. Kim HJ, Lee CH, Shin S, Lee JH, Kim YW, Chung HS, Han SK, Shim YS, Kim DK. The impact of nutritional deficit on mortality of in-patients with pulmonary tuberculosis. Int J Tuberc Lung Dis 2010, 14(1):79-85.
33. Wen CP, Chan TC, Chan HT, Tsai MK, Cheng TY, Tsai SP. The reduction of tuberculosis risks by smoking cessation. BMC Infect Dis 2010, 10:156. 10.1186/1471-2334-10-156, 2891758, 20529257.
34. Shen X, Deriemer K, Yuan Z, Shen M, Xia Z, Gui X, Wang L, Mei J. Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis 2009, 9:95. 10.1186/1471-2334-9-95, 2702371, 19531267.
35. Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newnham R, Githui W, Gathua S, Omwega M, McAdam K. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Am Rev Respir Dis 1992, 146(4):849-54.
36. Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. Nonadherence in tuberculosis treatment: predictors and consequences in New York city. Am J Med 1997, 102:164-170. 10.1016/S0002-9343(96)00402-0, 9217566.
37. Goble N, Iseman MD, Madson LA, Waite D, Ackerson L, Horsburgh CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. N Eng J Med 1993, 328:527-532.
38. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug resistant tuberculosis in New York City. N Engl J Med 1993, 328:521-526. 10.1056/NEJM199302253280801, 8381207.
39. Datta M, Radhamani MP, Selvaraj R, et al. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 1993, 74:180-186.
40. Kang'ombe C, et al. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up. Trans R Soc Trop Med Hyg 2000, 94:305-309. 10.1016/S0035-9203(00)90335-3, 10975007.
41. Buhl K, Nyboe J. Epidemiological basis of tuberculosis eradication - 9. Changes in the mortality of Danish tuberculosis patients since 1925. Bull WHO 1967, 37:907-925. 2554230, 5301648.
42. White MC, Portillo CJ. Tuberculosis mortality associated with AIDS and drug or alcohol abuse: analysis of multiple cause-of-death data. Publ Health 1996, 110:185-189.
43. Heldal E, Naalsund A, Kongerud J, Tverdal A, Boe J. Deaths from active tuberculosis: can we rely on notification and mortality figures?. Tubercle Lung Dis 1996, 77:215-219.